Hmgb1-TLR4-IL-23-IL-17A Axis Promote Ischemia-Reperfusion Injury in a Cardiac Transplantation Model

Background Cardiac transplantation is the last resort for patients with end-stage heart failure. Ischemia-reperfusion (IR) injury is a major issue in cardiac transplantation. Inflammatory processes play a major role in myocardial IR injury. However, the cellular and molecular immune mechanisms of myocardial IR injury remain elusive. Methods Hearts of C57BL/6 mice were flushed and stored in cold Bretschneider solution for 8 hr and then transplanted into syngeneic recipient. The involvement of high-mobility group box 1 (Hmgb1) and interleukin (IL)-17A was assessed in functional assays by neutralizing Hmgb1 or IL-17A. Results IL-17A was elevated after myocardial IR injury in cardiac transplantation. IL-17A was predominantly produced by &ggr;&dgr;T cells rather than CD4+ or CD8+ T cells infiltrated into the cardiac isografts. Neutralizing antibody against IL-17A or &ggr;&dgr;TCR attenuated cardiomyocyte apoptosis and neutrophil recruitment. Furthermore, a neutralizing IL-23p19 antibody decreased the level of IL-17A and neutrophil infiltration. Importantly, IL-23 and IL-17A were reduced after inhibition of macrophages and could not be induced in TLR4-/- mice after IR injury. Meanwhile, Hmgb1 increased after IR injury and the Hmgb1 inhibitor glycyrrhizin markedly reduced the production of IL-23 and IL-17A and ameliorated myocardial IR injury. Conclusion The Hmgb1-TLR4-IL-23-IL-17A axis contributes to cardiomyocyte apoptosis, neutrophil accumulation and IR injury in cardiac transplantation.

[1]  R. Sun,et al.  High‐mobility group box 1 (HMGB1)‐toll‐like receptor (TLR)4‐interleukin (IL)‐23‐IL‐17A axis in drug‐induced damage‐associated lethal hepatitis: Interaction of γδ T cells with macrophages , 2013, Hepatology.

[2]  M. Lotze,et al.  High‐mobility group box 1 activates caspase‐1 and promotes hepatocellular carcinoma invasiveness and metastases , 2012, Hepatology.

[3]  Jing Yuan,et al.  Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. , 2012, Journal of the American College of Cardiology.

[4]  Sihua Wang,et al.  CCR5 Blockade in Combination with Cyclosporine Increased Cardiac Graft Survival and Generated Alternatively Activated Macrophages in Primates , 2011, The Journal of Immunology.

[5]  A. Valujskikh,et al.  Interleukin-17 promotes early allograft inflammation. , 2010, The American journal of pathology.

[6]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[7]  P. Friedl,et al.  The Fibrin-Derived Peptide B&bgr;15-42 Significantly Attenuates Ischemia-Reperfusion Injury in a Cardiac Transplant Model , 2010, Transplantation.

[8]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[9]  S. Gaffen,et al.  Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in disease , 2010, Immunology.

[10]  Jing Yuan,et al.  The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. , 2010, Cytokine.

[11]  R. Strieter,et al.  IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. , 2010, The Journal of clinical investigation.

[12]  F. Mach,et al.  The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury , 2009, Thrombosis and Haemostasis.

[13]  E. Bettelli,et al.  IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. , 2009, Clinical immunology.

[14]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[15]  V. Kuchroo,et al.  Induction and effector functions of TH17 cells , 2008, Nature.

[16]  Y. Iwakura,et al.  IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+ T cells , 2008, The Journal of experimental medicine.

[17]  C. Dinarello,et al.  Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. , 2008, The Annals of thoracic surgery.

[18]  N. Frangogiannis.  Chemokines in ischemia and reperfusion , 2007, Thrombosis and Haemostasis.

[19]  R. Gottlieb,et al.  The Interplay between Pro-Death and Pro-Survival Signaling Pathways in Myocardial Ischemia/Reperfusion Injury: Apoptosis Meets Autophagy , 2006, Cardiovascular Drugs and Therapy.

[20]  E. Verrier,et al.  Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury , 2006, Circulation.

[21]  C. Dong.  Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells , 2006, Nature Reviews Immunology.

[22]  T. Mcclanahan,et al.  IL-23 Enhances the Inflammatory Cell Response in Cryptococcus neoformans Infection and Induces a Cytokine Pattern Distinct from IL-121 , 2006, The Journal of Immunology.

[23]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[24]  M. Bianchi,et al.  HMGB1: guiding immunity from within. , 2005, Trends in immunology.

[25]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[26]  C. Hunter,et al.  TLR Ligands Can Activate Dendritic Cells to Provide a MyD88-Dependent Negative Signal for Th2 Cell Development1 , 2005, The Journal of Immunology.

[27]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[28]  S. Gaffen,et al.  Interleukin‐17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment , 2004, Journal of leukocyte biology.

[29]  G. Freeman,et al.  TNF-α and H2O2 induce IL-18 and IL-18Rβ expression in cardiomyocytes via NF-κB activation , 2003 .

[30]  H. Katus,et al.  TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. , 2002, Cardiovascular research.

[31]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[32]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[33]  D. Mann,et al.  In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. , 2001, The Journal of infectious diseases.

[34]  D. Cucinotta,et al.  IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. , 2000, Cardiovascular research.

[35]  R. Guyton,et al.  Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. , 2000, Cardiovascular research.

[36]  Herbert J Zeh,et al.  High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.

[37]  H. Rabb,et al.  Lymphocytes and ischemia-reperfusion injury. , 2009, Transplantation reviews.

[38]  K. Ley,et al.  IL-17A-producing neutrophil-regulatory Tn lymphocytes , 2006, Immunologic research.